View in EDS PDF Full Text

Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.

Saved in:
Bibliographic Details
Title: Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.
Authors: Pyo KH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, South Korea., Rahman SMM; International Centre for Diarrhoeal Disease Research (iccdr,b), Dhaka, Bangladesh., Boraschi D; Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China.; Institute of Biochemistry and Cell Biology, National Research Council (CNR), Napoli, Italy.; Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy.; China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, China.
Source: Frontiers in oncology [Front Oncol] 2023 Jan 10; Vol. 12, pp. 1121120. Date of Electronic Publication: 2023 Jan 10 (Print Publication: 2022).
Publication Type: Editorial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36703780
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pyo+KH%22">Pyo KH</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Rahman+SMM%22">Rahman SMM</searchLink>; International Centre for Diarrhoeal Disease Research (iccdr,b), Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Boraschi+D%22">Boraschi D</searchLink>; Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), Shenzhen, China.; Institute of Biochemistry and Cell Biology, National Research Council (CNR), Napoli, Italy.; Stazione Zoologica Anton Dohrn (SZN), Napoli, Italy.; China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Jan 10; Vol. 12, pp. 1121120. <i>Date of Electronic Publication: </i>2023 Jan 10 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36703780
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.1121120
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1121120
    Titles:
      – TitleFull: Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pyo KH
      – PersonEntity:
          Name:
            NameFull: Rahman SMM
      – PersonEntity:
          Name:
            NameFull: Boraschi D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 01
              Text: 2023 Jan 10
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1